辅酶Q10注射液联合左卡尼汀对老年慢性肺源性心脏病并心功能不全的疗效分析

doi:10.3969/j.issn.1006-6233.2019.09.021

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1271 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要 目的:探讨辅酶Q10注射液联合左卡尼汀对老年慢性肺源性心脏病并心功能不全的疗效。方法:选择2015年1月至2018年5月我院接诊的老年慢性肺源性心脏病并心功能不全患者86例,随机数表法分为观察组45例和对照组41例,在常规治疗基础上,对照组给予左卡尼汀治疗,观察组在对照组基础上,联合辅酶Q10注射液治疗,均连续治疗3周。比较两组临床疗效、血液流变学、血气分析、心功能及不良反应。结果:治疗后,观察组临床疗效总有效率明显比对照组高(P<0.05);观察组全血粘度高切、全血粘度低切、血浆粘度、全血还原粘度均明显低于对照组(P<0.05);观察组血氧分压(PaO₂)明显高于对照组,二氧化碳分压(PaCO₂)明显低于对照组(P<0.05);观察组心率(HR)、左心室舒张末期内径(LVEDD)明显低于对照组,左室射血分数(LVEF)明显高于对照组,6min步行距离明显长于对照组(P<0.05);两组治疗期间不良反应差异无统计学意义(P>0.05)。结论:辅酶Q10注射液联合左卡尼汀用于老年慢性肺源性心脏病并心功能不全患者疗效显著,且安全性高。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	邱荣
	郭莘
	郭华
	田静

关键词 ：慢性肺源性心脏病, 心功能不全, 辅酶Q10注射液, 左卡尼汀, 血液流变学

Abstract：Objective: To study the curative efficacy of coenzyme Q10 injection combined with levocarnitine in treatment of senior chronic pulmonary heart disease with cardiac insufficiency. Methods: 86 patients of senior chronic pulmonary heart disease with cardiac insufficiency who received therapy from January 2015 to May 2018 in our hospital were selected as research objects, according to random number table, those patients were divided into the 45 cases of the observation group and 41 cases of the control group, on the basis of routine treatment, the control group was treated with levocarnitine, while the observation group was treated with coenzyme Q10 injection on the basis of the control group, they were treated for 3 weeks. The clinical efficacy, hemorheology, blood gas analysis, cardiac function and adverse reactions were compared between the two groups. Results: After treatment, the total effective rate of the observation group was significantly higher than those in the control group (P＜0.05); The whole blood viscosity, high shear rate, low shear rate, plasma viscosity and whole blood reduced viscosity in the observation group were significantly lower than those in the control group (P＜0.05); the partial pressure of oxygen (PaO₂) in the observation group was significantly higher than those in the control group, and the partial pressure of carbon dioxide (PaCO₂) in the observation group was significantly lower than those in the control group (P＜0.05); the heart rate (HR) and left ventricular end-diastolic diameter (LVEDD) in the observation group were significantly lower than those in the control group, the left ventricular ejection fraction (LVEF) was significantly higher than those in the control group, and the 6-minute walking distance was significantly longer than those in the control group (P＜0.05); there was no significant difference in adverse reactions between the two groups during treatment (P＞0.05). Conclusion: Coenzyme Q10 injection combined with levocarnitine is well for senior chronic pulmonary heart disease with cardiac insufficiency, and has good drug safety

Key words： Chronic pulmonary heart disease Cardiac insufficiency Coenzyme Q10 injection Levocarnitine Hemorheology

基金资助:天津市自然科学基金项目,(编号:2013117)

引用本文:

邱荣, 郭莘, 郭华, 田静. 辅酶Q10注射液联合左卡尼汀对老年慢性肺源性心脏病并心功能不全的疗效分析[J]. 河北医学, 2019, 25(9): 1488-1493.
QIU Rong, GUO Shen, GUO Hua, et al. Exploring the Effect of Coenzyme Q10 Injection Combined with Levocarnitine on Elderly Patients with Chronic Pulmonary Heart Disease and Cardiac Insufficiency. HeBei Med, 2019, 25(9): 1488-1493.

链接本文:

http://www.hbyxzzs.cn/CN/10.3969/j.issn.1006-6233.2019.09.021 或 http://www.hbyxzzs.cn/CN/Y2019/V25/I9/1488

[1] 杨福纯.老年慢性肺源性心脏病心力衰竭的相关因素及临床诊治方法探讨[J].中国实用医药,2018,13(33):41~42.
[2] Ranque B, Menet A, Boutouyrie P, et al. Arterial stiffness impairment in sickle cell disease associated with chronic vascular complications: the multinational african CADRE study[J]. Circulation, 2016, 134(13): 923~933.
[3] 吴寿荣,刘光金,卢丽萍.肺心病急性加重期患者血液流变学及凝血功能指标监测的临床意义[J].标记免疫分析与临床,2017,24(8):905~907.
[4] Dadabayev AR, Yin G, Latchoumycandane C, et al. Apolipoprotein A1 regulates coenzyme Q10 absorption, mitochondrial function, and infarct size in a mouse model of myocardial infarction[J].Nutr, 2014, 144(7): 1030~1036.
[5] 董承琅,陶寿琪,陈灏珠.实用心脏病学[M].第3版.上海:上海科学技术出版社,1993.1009.
[6] 国家卫生计生委合理用药专家委员会,中国药师协会.心力衰竭合理用药指南[J].中国医学前沿杂志(电子版),2016,8(09):19~66.
[7] 葛均波,徐永健.内科学[M].第8版.北京:人民卫生出版社,2013.174~177.
[8] Esposito R, Sorrentino R, Galderisi M. The use of transthoracic echocardiography for the assessment of left ventricular systolic and diastolic function in patients with suspected or ascertained chronic heart failure[J]. Expert Rev Cardiovasc Ther, 2016, 14(1): 37~50.
[9] 张雁,来锦,杨孝菊,等.血液流变学的临床应用与影响因素[J].承德医学院学报,2016,33(03):236~239.
[10] 杨继雷,姚秀叶,谷伟,等.参脉注射液联合左卡尼汀对老年肺心病心力衰竭期心功能及血清Copeptin、NT-proBNP、hs-cTnT的影响[J].疑难病杂志,2016,15(04):340~343.
[11] Cruz WMS, Guimaraes SMS, Maciel GC, et al. L-carnitine supplementation in the recovery of plasma L-carnitine in patients with heart failure submitted to coronary artery bypass grafting[J]. An Acad Bras Cienc, 2018, 90(3): 3099~3104
[12] Kabirian A, Batavani RA, Asri-Rezaei S, et al. Comparative study of the protective effects of chicken embryo amniotic fluid, vitamin C and coenzyme Q10 on cyclophosphamide-induced oxidative stress in mice ovaries[J]. Vet Res Forum, 2018, 9(3): 217~224.
[13] 王文娜,陈明.辅酶Q10心血管病防治应用进展[J].心血管病学进展,2017,38(02):184~189.
[14] Povarova OV, Balatsky AV, Gusakov VS, et al. Effect of coenzyme Q10 on epression of ubiAd1 gene in rat model of local cerebral ischemia[J]. Bull Exp Biol Med, 2018, 165(1): 69~71.
[15] Jorat MV, Tabrizi R, Mirhosseini N, et al. The effects of coenzyme Q10 supplementation on lipid profiles among patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials[J]. Lipids Health Dis, 2018, 17(1): 230.